News

From the College of Natural Sciences
Ancient Enzyme Could Boost Power of Liquid Biopsies to Detect and Profile Cancers

Ancient Enzyme Could Boost Power of Liquid Biopsies to Detect and Profile Cancers

Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University of Texas at Austin are developing a new tool for liquid biopsy that could soon provide doctors with a more complete picture of an individual's disease, improving their chances of finding the best treatment, while also sparing patients the pain, inconvenience and long wait times associated with surgical biopsies.

Stone Named Emerging Inventor of the Year

Stone Named Emerging Inventor of the Year

Everett Stone, a research assistant professor in the Department of Molecular Biosciences at The University of Texas at Austin, has been named the 2017 Emerging Inventor of the Year by the university's Office of Technology Commercialization. The award is given to recognize faculty members who excel in their fields and whose work produces practicable innovations and life-changing discoveries.

Chemists Receive $2 Million to Develop Inexpensive Home Test for Heart Failure

Chemists Receive $2 Million to Develop Inexpensive Home Test for Heart Failure

With the prick of a finger, the new sensor could indicate whether a person has elevated levels of a biomarker associated with heart failure. Credit: iStock.

The National Institutes of Health (NIH) has awarded a team led by Richard M. Crooks, a chemistry professor at The University of Texas at Austin, a $2 million grant to develop an inexpensive, at-home test for people diagnosed with heart failure.

Scientists Discover Powerful Potential Pain Reliever

Scientists Discover Powerful Potential Pain Reliever

Stephen Martin (left) and James Sahn have discovered a new pain reliever that acts on a previously unknown pain pathway. Photo Credit: Courtesy of Stephen Martin.

A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic compound, known as UKH-1114, is as effective at relieving neuropathic pain in injured mice as a drug widely used for pain relief called gabapentin, but it works at a much lower dose, with longer duration of action.

UT Austin Leads $29 Million Alcoholism Treatment Consortium

UT Austin Leads $29 Million Alcoholism Treatment Consortium

The National Institutes of Health has awarded an international consortium seeking better pharmaceutical treatments for alcoholism a five-year grant totaling $29 million. The administrative headquarters and several of the projects will be at The University of Texas at Austin, which will receive $8.5 million of the total.

Unlocking the Mysteries of Life-Changing Hepatitis C Drugs

Unlocking the Mysteries of Life-Changing Hepatitis C Drugs

Researchers at the University of Texas at Austin have for the first time revealed how a group of drugs that are being developed to treat hepatitis C works. Pharmaceutical companies might be able to apply these new insights to future drugs designed to address a deadly disease.

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

Researchers at The University of Texas at Austin successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA).

Chemistry in Mold Reveals Important Clue for Pharmaceuticals

Chemistry in Mold Reveals Important Clue for Pharmaceuticals

​In a discovery that holds promise for future drug development, scientists have detected for the first time how nature performs an impressive trick to produce key chemicals similar to those in drugs that fight malaria, bacterial infections and cancer.

Freshman Researchers Receive Grand Challenges Explorations Grant

Freshman Researchers Receive Grand Challenges Explorations Grant

University of Texas at Austin freshmen, working to develop do-it-yourself health care diagnostics, make up a research group that was announced today as a Grand Challenges Explorations winner, through an initiative funded by the Bill & Melinda Gates Foundation.

Two Elected to the American Academy of Arts and Sciences

Two Elected to the American Academy of Arts and Sciences

The American Academy of Arts and Sciences announced this week the election of two new members from The University of Texas at Austin—mathematician Björn Engquist and biochemist George Georgiou.